0001140361-15-045654.txt : 20151228 0001140361-15-045654.hdr.sgml : 20151225 20151228142004 ACCESSION NUMBER: 0001140361-15-045654 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151223 FILED AS OF DATE: 20151228 DATE AS OF CHANGE: 20151228 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Emergent BioSolutions Inc. CENTRAL INDEX KEY: 0001367644 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 141902018 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 PROFESSIONAL DR, SUITE 400 CITY: GAITHERSBURG STATE: MD ZIP: 20879 BUSINESS PHONE: 240-631-3200 MAIL ADDRESS: STREET 1: 400 PROFESSIONAL DR, SUITE 400 CITY: GAITHERSBURG STATE: MD ZIP: 20879 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Abdun-Nabi Daniel CENTRAL INDEX KEY: 0001380187 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33137 FILM NUMBER: 151308933 MAIL ADDRESS: STREET 1: 2273 RESEARCH BLVD, SUITE 400 CITY: ROCKVILLE STATE: MD ZIP: 20850 4 1 doc1.xml FORM 4 X0306 4 2015-12-23 0 0001367644 Emergent BioSolutions Inc. EBS 0001380187 Abdun-Nabi Daniel 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 1 1 0 0 President & CEO Common Stock 2015-12-23 4 M 0 40354 18.90 A 225722 D Common Stock 2015-12-23 4 S 0 40354 38.99 D 185368 D Common Stock 2015-12-24 4 M 0 22855 18.90 A 208223 D Common Stock 2015-12-24 4 S 0 22855 39.17 D 185368 D Stock Option 18.90 2015-12-23 4 M 0 40354 0 D 2019-03-09 Common Stock 40354 22855 D Stock Option 18.90 2015-12-24 4 M 0 22855 0 D 2019-03-09 Common Stock 22855 0 D Consists of an option granted under the company's stock incentive plan on March 10, 2009. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Abdun-Nabi. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.79 to $39.11, inclusive. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.99 to $39.48, inclusive. The option vested in three equal installments in March 2010, 2011 and 2012. /s/ Eric Burt, attorney-in-fact 2015-12-28